Indian Psychiatric Society Survey on Clinical Practice Guidelines

AIM: This survey aimed to assess the utility of the earlier published clinical practice guidelines (CPGs) by IPS and to understand the expectations of members of Indian Psychiatric Society from the proposed revised CPGs. In addition, the survey also evaluated the current level of practice of psychiatry in terms of availability of different investigation facilities, prescription patterns in terms of use of polypharmacy, and competence in carrying out certain nonpharmacological treatments. METHODOLOGY: An online survey was received by 3475 psychiatrist, of whom 608 (17.5%) participants completed the survey. RESULTS: Almost all (93.8%) of the psychiatrists agreed that there should be separate CPGs for Indian setting. In terms of problems with the previous version of the CPGs, this survey shows that the previous version of guidelines was used in making clinical decisions by only one-third (31.25%) of the participating psychiatrists. The major limitations of the previous version of CPGs which were pointed out included the lack of consideration of socio-cultural issues (33.2%), lack of recommendations for many clinical situations that are encountered in clinical practice (43.15) and poor dissemination (35.2%). In terms of expectations, the membership expects the society to come up with guidelines, which are shorter in length (82.2%), has significant proportion of information in the form of tables and flow diagrams (58.7%), besides the evidence base must also take expert opinions into account (84.7%), must be circulated before adopting (88.7%), must be disseminated by displaying the same on the website (72%), and also by sending the same by E-mails (62%). Further, the membership expects the IPS to design online continuing medical education program on CPGs (54.3%). The survey also suggests that it is feasible on the part of more than two-third of the psychiatrists to monitor the metabolic parameters in routine clinical practice and carryout various nonpharmacological treatments. Majority of the psychiatrist opined that polypharmacy is not used in more than 25% of patients with schizophrenia and depression and hence the use of polypharmacy should be recommended judiciously. CONCLUSION: This survey shows that the membership of the IPS is interested in having own guidelines for the management of various psychiatric disorders in Indian setting. Further, the survey provides insights into why the previous versions of the guidelines were not very popular and what IPS should do improve the acceptability of guidelines in future.